Suppr超能文献

库拉里诺综合征中HLXB9基因突变谱及基因型-表型相关性

Spectrum of HLXB9 gene mutations in Currarino syndrome and genotype-phenotype correlation.

作者信息

Crétolle C, Pelet A, Sanlaville D, Zérah M, Amiel J, Jaubert F, Révillon Y, Baala L, Munnich A, Nihoul-Fékété C, Lyonnet S

机构信息

Université Paris Descartes, Faculté de Médecine, INSERM U781, Site Necker, Paris, France.

出版信息

Hum Mutat. 2008 Jul;29(7):903-10. doi: 10.1002/humu.20718.

Abstract

Currarino syndrome (CS) is a rare congenital malformation described in 1981 as the association of three main features: typical sacral malformation (sickle-shaped sacrum or total sacral agenesis below S2), hindgut anomaly, and presacral tumor. In addition to the triad, tethered cord and/or lipoma of the conus are also frequent and must be sought, as they may lead to severe complications if not treated. The HLXB9 gene, located at 7q36, is disease-causing. It encodes the HB9 transcription factor and interacts with DNA through a highly evolutionarily conserved homeodomain early in embryological development. Thus far, 43 different heterozygous mutations have been reported in patients fulfilling CS criteria. Mutation detection rate is about 50%, and reaches 90% in familial cases. Here, we report 23 novel mutations in 26 patients among a series of 50 index cases with CS, and review mutational reports published since the identification of the causative gene. Three cytogenetic anomalies encompassing the HLXB9 gene are described for the first time. Truncating mutations (frameshifts or nonsense mutations) represent 57% of those identified, suggesting that haploinsufficiency is the basis of CS. No obvious genotype-phenotype correlation can be drawn thus far. Genetic heterogeneity is suspected, since at least 19 of the 24 patients without HLXB9 gene mutation harbor subtle phenotypic variations.

摘要

库里亚里诺综合征(CS)是一种罕见的先天性畸形,于1981年被描述为具有三个主要特征:典型的骶骨畸形(镰刀形骶骨或S2以下完全骶骨发育不全)、后肠异常和骶前肿瘤。除了这三联征外,脊髓栓系和/或圆锥脂肪瘤也很常见,必须进行排查,因为如果不治疗,它们可能会导致严重并发症。位于7q36的HLXB9基因是致病基因。它编码HB9转录因子,并在胚胎发育早期通过高度进化保守的同源结构域与DNA相互作用。迄今为止,在符合CS标准的患者中已报道了43种不同的杂合突变。突变检测率约为50%,在家族性病例中达到90%。在此,我们报告了50例CS索引病例系列中的26例患者中的23种新突变,并回顾了自致病基因鉴定以来发表的突变报告。首次描述了三种包含HLXB9基因的细胞遗传学异常。截短突变(移码突变或无义突变)占已鉴定突变的57%,这表明单倍体不足是CS的基础。迄今为止,尚无法得出明显的基因型-表型相关性。由于24例无HLXB9基因突变的患者中至少有19例存在细微的表型变异,因此怀疑存在遗传异质性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验